Why Must We Keep Discussing Strategic Purchasing and Managed Competition?; Comment on “Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands”
Stadhouders and colleagues’ new measure answers an important question: Do strategic purchasing and managed competition redirect healthcare resources, and, if so, when, how, and to what? Applying it to the Netherlands, they find that they do not. This commentary first examines logical problems in arguments for strategic purchasing and managed competition, and then briefly reviews other evidence of their very limited success from, in particular, the Netherlands and England. It then raises the question of why strategic purchasing and managed competition continue to be advocated despite the poor logic of the arguments behind them and substantial evidence that they do not work.
Stadhouders NW, Koolman X, Tanke MAC, Maarse H, Jeurissen PPT. Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands. Int J Health Policy Manag. 2023;12:7506. doi:34172/ijhpm.2023.7506
van Ginneken E. Governing competitive insurance market reform: case studies from the Netherlands and Switzerland. In: Greer SL, Wismar M, Figueras J, eds. Strengthening Health Systems Governance: Better Policies, Stronger Performance. Brussels: European Observatory on Health Systems and Policies, Open University Press; 2016:129-142.
Siciliani L, Chalkley M, Gravelle H. Does Provider Competition Improve Health Care Quality and Efficiency? Brussels: European Observatory on Health Systems and Policies; 2022.
Klein R. The New Politics of the NHS: From Creation to Reinvention. Oxford: Radcliffe Medical; 2006.
Greer SL, Kulikoff R. The future of global health, without the United States. Bull At Sci. 2025;81(3):188-194. doi:1080/00963402.2025.2488675
Enthoven AC. The history and principles of managed competition. Health Aff (Millwood). 1993;12 Suppl:24-48. doi:1377/hlthaff.12.suppl_1.24
Marmor T. Fads in Medical Care Policy and Politics: The Rhetoric and Reality of Managerialism. London: The Nuffield Trust [Rock Carling Fellowship Lecture 2001]; 2001.
Greer SL, Klasa K, E VANG. Power and purchasing: why strategic purchasing fails. Milbank Q. 2020;98(3):975-1020. doi:1111/1468-0009.12471
Montás MC, Klasa K, van Ginneken E, Greer SL. Strategic purchasing and health systems resilience: lessons from COVID-19 in selected European countries. Health Policy. 2022;126(9):853-864. doi:1016/j.healthpol.2022.06.005
Paton C. NHS Reform and Health Politics in the UK: Revolution, Counter-Revolution and COVID Crisis. Springer Nature; 2022.
Powell M, Mannion R, Exworthy M. The NHS at 75: The State of UK Health Policy. Policy Press; 2023.
Osipovič D, Allen P, Shepherd E, et al. Interrogating institutional change: actors' attitudes to competition and cooperation in commissioning health services in England. Public Adm. 2016;94(3):823-838. doi:1111/padm.12268
Checkland K, Snow S, McDermott I, Harrison S, Coleman A. 'Animateurs' and animation: what makes a good commissioning manager? J Health Serv Res Policy. 2012;17(1):11-17. doi:1258/jhsrp.2011.011010
Ban C. Ruling Ideas: How Global Neoliberalism Goes Local. Oxford University Press; 2016.
Singh Y, Fuse Brown E, Papanicolas I. The rise of private equity in health care - not a uniquely American phenomenon. N Engl J Med. 2025;392(7):627-629. doi:1056/NEJMp2412002
Articles in Press, Corrected Proof Available Online from 14 July 2025
Greer, S. L. (2025). Why Must We Keep Discussing Strategic Purchasing and Managed Competition?; Comment on “Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands”. International Journal of Health Policy and Management, (), -. doi: 10.34172/ijhpm.9248
MLA
Greer, S. L. . "Why Must We Keep Discussing Strategic Purchasing and Managed Competition?; Comment on “Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands”", International Journal of Health Policy and Management, , , 2025, -. doi: 10.34172/ijhpm.9248
HARVARD
Greer, S. L. (2025). 'Why Must We Keep Discussing Strategic Purchasing and Managed Competition?; Comment on “Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands”', International Journal of Health Policy and Management, (), pp. -. doi: 10.34172/ijhpm.9248
CHICAGO
S. L. Greer, "Why Must We Keep Discussing Strategic Purchasing and Managed Competition?; Comment on “Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands”," International Journal of Health Policy and Management, (2025): -, doi: 10.34172/ijhpm.9248
VANCOUVER
Greer, S. L. Why Must We Keep Discussing Strategic Purchasing and Managed Competition?; Comment on “Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands”. International Journal of Health Policy and Management, 2025; (): -. doi: 10.34172/ijhpm.9248